The Institute for Clinical and Economic Review’s (ICER) founder Steven Pearson during an interview with the Boston Globe described the drug-pricing watchdog as the “mouse that roared,” adding that it refuses to back down against “huge companies, huge resources, huge everything.”
Pearson tells the Globe ICER isn’t looking to paint a bad guy, either, and wants to find a solution that benefits all stakeholders.
“We’re not here to tell the pharmaceutical industry that they’re evil,” Pearson said. “We’re not here to tell the payers that they’re evil. We’re here to find the win-win by providing an independent look at the evidence.”
To read the full report on the Globe, click here.